Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix, STMicroelectronics to Combine Techs for Dx Apps

NEW YORK, June 29 (GenomeWeb News) - CombiMatrix will combine its ElectroChemical Detection Technology with STMicroelectronics In-Check Lab-on-Chip platform to investigate their applications in the research and point-of-care diagnostics markets, the companies said today.

 

Terms of the deal call for ST to provide undisclosed financial support to CombiMatrix in this work.

ST's In-Check DNA amplification and analysis platform, when combined with CombiMatrix microarrays, may enable it to be "as sensitive, or more sensitive," than current fluorescent/optical detection techniques and provide a number of advantages over optical detection, the firms said.

Financial terms of the alliance were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.